SAShimpei Araki

Shimpei Araki

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shimpei Araki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Controlled Hypoalbuminemia Due to High Albumin Leakage Is Associated with Lower Mortality in Old-Old Patients with Mild Weight Loss and/or Inflammation

    by Kazuyoshi Okada, Manabu Tashiro, Hiroyuki Michiwaki, Daisuke Hara, Shimpei Araki, Ryo Mochizuki, Tomoko Inoue, Takahiro Kuragano, Jun Minakuchi

    Controlled hypoalbuminemia due to high albumin leakage (Alb-L) improves mortality in dialysis patients with mild weight loss and/or inflammation. However, no study has investigated whether it reduces mortality in old-old patients who tend to have progressively worsening hypoalbuminemia, weight loss, and inflammation over time. To address this question, this study retrospectively analyzed 227 dialysis patients aged ≥75 years who were classified into a high Alb-L group (≥3 g/session, n = 93) and a low Alb-L group (2, high-sensitivity C-reactive protein (hs-CRP) level ≥0.3 mg/dL, and a group with BMI 2 and/or hs-CRP level ≥0.3 mg/dL were associated with lower mortality rates in high Alb-L than in low Alb-L, while no associations were observed for BMI 2, hs-CRP level 2 and hs-CRP <0.3 mg/dL. Although low Alb-L was associated with reduced S-Alb and BMI, and elevated serum creatinine (S-Cr) after 3 years, high Alb-L were associated with increased BMI, decreased S-Cr, and the prevention of reduced S-Alb level. Furthermore, in patients without inflammation, either high or low Alb-L was associated with elevated hs-CRP level after 3 years. In contrast, controlled hypoalbuminemia due to high Alb-L was associated with decreased hs-CRP level in patients with mild inflammation, but low Alb-L was not. Controlled hypoalbuminemia due to high Alb-L was associated with lower mortality relative to low Alb-L in exploratory analyses of patients aged ≥75 years with mild weight loss and/or inflammation.